Potential Swing Catalyst For Gains In Bellerophon Therapeutics, Inc. ($BLPH)


  • Great buy-in: $0.6258-$0.63
  • Anticipated swing(s): $0.63-$0.70+
  • Return On Investment (ROI): 10% swings
  • Return On Investment (ROI) w/ positive catalyst: 20%+

What’s going on guys!!!! Hope someone out there grabbed some $ATHX when I posted my article last week.

Athersys Announces Fast Track Designation From FDA for MultiStem® Program for Acute Respiratory Distress Syndrome

o   ATHX saw a spike of 15% today 05/14/2019. I personally did three swing trades for 12% profit; I will stick to my strategy of holding until news this time (maybe) lol. I like to take my profits when I can!

I found my next swing on $BLPH on anticipation of positive data Monday (05/20/2019). Will I go into detail you ask? YOU KNOW IT! LET’S GET TO IT!

 

Recent positive PR:

-Phase 2b cohort 2 data and pivotal cohort 3 (Phase 3) initiation due 2H 2019. Additional cohort 1 data due to be presented at ATS May 20, 2019.

Summary of First Quarter 2019 Financial Results 05/19/2019 from $BLPH:

  • PH-ILD:  The Company announced positive results from Cohort 1 of its ongoing iNO-PF trial.
  • Company reported a net loss of $0.8 million
    - Not too bad.
  • Adjustment of $1.6 million due to a change in fair value of common stock warrant liability, as compared to an adjustment of $7.1 million for the three months ended March 31, 2018.
    - This caused an over reaction in the markets, which gives perfect opportunity for a great swing. It is slowly starting to recover from the sell offs on earnings.
  • Research and development expenses for the three months ended March 31, 2019 were $2.3 million compared to $6.4 million in the prior year period.  The decrease was primarily due to the conclusion of the INOvation-1 PAH trial, which was partially offset by increased activity in the PH-ILD Phase 2b program.
    - This explains the massive overreaction, but this is actually pretty good and explains how they only reported a net loss of $0.8M.
  • Cash and cash equivalents of $20.7 million, compared to $16.6 million at December 31, 2018.
  • Included the net proceeds from the $7 million public offering of common stock completed in January 2019, and an additional $1.7 million received in January 2019 from the sale of the Company’s tax net operating losses in the State of New Jersey.

TECHNICALS:05/14/2019: 1D 30M

Resistance: $0.6498
High of Day: $0.6498
Support: $0.6268
Next step down: $0.60

  1. Over reaction from the markets after the earnings leaves room to grab some at discount. A realistic buy-in for me would be at the pull back to .6268… I would be happy grabbing some after confirmation, most likely will be 0.65-0.66.
  2. RSI Indicates that it is in the middle now, not oversold nor overbought. The RSI is pointing downwards which is an indicator of a sell off, so .60 possible this week (keeping eye on it).
  3. MACD is also indicating a pull back. If I see a bounce off MACD tomorrow at 0.60-0.62 I would load up.

ANALYST RATINGS:

Although analysts’ ratings are always cool never go off their estimates. Do your due diligence based off technicals, volume leading up to events, etc.…

Jan-24-19 Initiated Maxim Group Buy $3
Apr-17-17 Initiated Ladenburg Thalmann Buy $4.50
Jan-20-17 Initiated H.C. Wainwright Buy $5

Good luck to myself and ALL. Let’s go green again, good luck bulls!!!

Disclaimer: Do your Due Diligence, just sharing my opinion. I cannot predict the market, but if you compare past behaviors... this is a great ticker to setup for a swing when the market overreacts.

Lock-in profits - do not get greedy!

Leave a comment